2015
DOI: 10.1111/jcpe.12371
|View full text |Cite
|
Sign up to set email alerts
|

Hyaluronan in non‐surgical and surgical periodontal therapy: a systematic review

Abstract: Hyaluronan application as adjunct to non-surgical and surgical periodontal treatment seems to have a beneficial, generally moderate, effect on surrogate outcome variables of periodontal inflammation, i.e., BoP and residual PD, and appears to be safe. The large heterogeneity of included studies, does not allow recommendations on the mode of application or effect size of HY as adjunct to non-surgical and surgical periodontal treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
83
1
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(91 citation statements)
references
References 61 publications
4
83
1
3
Order By: Relevance
“…Therefore, a significant decline of PD (0.2-0.9 mm) and BOP (2.28-19.5 %) compared to control groups has been observed in clinical studies using HA at different concentrations and dosage forms [20]. Noteworthy, the application mode of HA and the appropriate carrier system are important parameters for periodontitis therapy [20]. Therefore, the aim of the present study was to examine the biocompatibility of HA administered on dentin and the consequent biological outcome on periodontal ligament (PDL) cells in vitro.…”
Section: Introductionmentioning
confidence: 94%
See 1 more Smart Citation
“…Therefore, a significant decline of PD (0.2-0.9 mm) and BOP (2.28-19.5 %) compared to control groups has been observed in clinical studies using HA at different concentrations and dosage forms [20]. Noteworthy, the application mode of HA and the appropriate carrier system are important parameters for periodontitis therapy [20]. Therefore, the aim of the present study was to examine the biocompatibility of HA administered on dentin and the consequent biological outcome on periodontal ligament (PDL) cells in vitro.…”
Section: Introductionmentioning
confidence: 94%
“…Moreover, HA has been linked with minimizing early bacterial recolonialization after and in combination with mechanical debridement [18,19]. Therefore, a significant decline of PD (0.2-0.9 mm) and BOP (2.28-19.5 %) compared to control groups has been observed in clinical studies using HA at different concentrations and dosage forms [20]. Noteworthy, the application mode of HA and the appropriate carrier system are important parameters for periodontitis therapy [20].…”
Section: Introductionmentioning
confidence: 98%
“…A number of studies describe the use of exogenous HA in non‐surgical and surgical periodontal therapy with generally beneficial but moderate effects on surrogate outcome variables of periodontal inflammation, ie, bleeding on probing and residual pocket depth . However, only few studies exist on the use of HA in reconstructive periodontal surgery .…”
Section: Introductionmentioning
confidence: 99%
“…However, these studies are not complete and cover only some clinical applications such as HA application in periodontal disease. 20 The aim of the study is: to systematically review the published literature regarding all the therapeutic effects of HA on acute and chronic inflammatory disease in oral cavity; to clarify and classify the main application areas of HA in dentistry, the pathophysiological basis, and the schedule of postoperative HA application; and to evaluate the most effective parameters of HA use in the field of odontostomathology.…”
Section: Introductionmentioning
confidence: 99%